Punctal

QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System

VANCOUVER, July 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: QLT) ("QLT" or the "Company") today announced encouraging interim data from an ongoing Phase II clinical trial and a device study for the punctal plug delivery system. These studies are part of a development program that i...

QLT announces encouraging Phase II data from core study of Punctal Plug Drug Delivery System

Sustained release treatment leads to reduction in IOP of 20% from baseline at 12 weeks VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced data from its CORE study, a Phase II trial being conducted by QLT's wholly-owned subsid...

QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension

VANCOUVER, March 31 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today the initiation of patient recruitment into its "CORE" study, a phase II trial being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. ("QPD"), to evaluate the preliminary efficacy a...

QLT Announces Second Quarter Results for 2009

... "We remain very focused on the development of our punctal plug program and continue to make innovative advan...ntinue to strongly believe in the potential of our punctal plug delivery technology for broad use in ocular d...08 more than offset higher spending related to our punctal plug program. Also of note, in the second quarter,...

QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy

...ize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne(R) and Eligard(R) and...s and technologies (including Visudyne-Lucentis combination therapy and our punctal plug technology) and the associated costs of these programs; the timing, ex...

LASIK Specialist Board Certified Eye Surgeon Dr. Kevin Niksarli, M.D. of Manhattan Lasik Center Announces Website Update

... in the New York, New Jersey area. These include laser vision correction, LASIK, bladeless LASEK, Intralase LASIK, CK, Intacs, Intraocular lenses, and punctal plugs, among others. Kevin Niksarli, M.D. ,of Manhattan Lasik Center, a diplomate of the American Board of Ophthalmology (ABO), is a board certif...

QLT announces positive results from the evaluation of Visudyne(R) combination therapy

...ize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne(R) and Eligard(R) and...es (including reduced-fluence Visudyne-Lucentis combination therapy and our punctal plug technology) and the associated costs of these programs; the timing, ex...

QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court

...pharmaceutical products in the field of ophthalmology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne(R) and Eligard(R) and future product opportunities. For more information, visit our web site at ...

QLT announces first quarter results for 2009

... to sharing the results from our on-going Phase II punctal plug program in the third quarter. In addition, in...08 more than offset higher spending related to our punctal plug program. Operating Income/Loss Oper...g a valuation allowance against the tax benefit of punctal plug development expenditures. The effective tax r...

QLT announces completion of Phase Ia safety trial of its synthetic retinoid product

...pharmaceutical products in the field of ophthalmology. In addition, we utilize three unique technology platforms, photodynamic therapy, Atrigel(R) and punctal plugs with drugs, to create products such as Visudyne(R) and Eligard(R), and future product opportunities. For more information, visit our web site at...

Punctal in Medical Products

UltraPlug Extended Wear Punctal Plugs

Description: Inserted into the punctal opening to block tear drainage through the canaliculus, synthetic absorbable plugs provide extended temporary relief of dry eye symptoms: Indicated for use in the treatment of Dry Eye Syndrome and the dry eye components of various ocular surface diseases May be used aft...
Company:Surgical Specialties

UltraPlug Collagen Absorbably Punctal Plugs

Description: Inserted into the punctal opening to block tear drainage through the canaliculus, collagen plugs provide temporary relief of dry eye symptoms: Manufactured from precisely measured premium collagen Used as a diagnostic assessment for permanent punctal occlusion Available in standard and short le...
Company:Surgical Specialties

Parasol Punctal Occluder

Description: One glance at the Parasol Punctal Occluder System and you'll recognize a breakthrough patented product which offers several distinct advantages to you and your dry eye patients. Easy to Insert. The Parasol's hollow nose collapses on insertion, eliminating the need for punctal dilation in most cas...
Company:Odyssey Medical

UltraPlug Silicone Punctal Plugs

Description: Inserted into the punctal opening to block tear drainage through the canaliculus, silicone plugs provide long-term relief of dry eye symptoms, and enable the eye to retain more of its own natural tears: Low-profile cap design virtually eliminates foreign body sensation Flexibility of cap design ...
Company:Surgical Specialties

Tears Naturale Punctal Plugs

Description: Patients who need punctal occlusion want more than just dry eye relief. They also want their punctal plug to be as comfortable and as unobtrusive as possible. Which is why Alcon punctal plugs are growing in popularity with eye care professionals and their patients everywhere....
Company:Alcon Laboratories

EXTEND Absorbable Synthetic Implants

Description:... EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also avai...
Company:Odyssey Medical

Self-Retaining Bicanaliculus Intubation Set

Description:...lets fold backwards for easy removal of the stent from the ducts. Primary indications for the SRS include horizontal lacrimal duct stricture and punctal stenosis. Special consideration should be given to cancer patients on constricting drug therapies such as Taxotere....
Company:FCI Ophthalmics Inc.

Form Fit Intracanalicular Plugs

Description:...expands into a soft, pliable, gelatinous material when it contacts tear film. The Form Fit is easily removable by flushing saline solution through the punctal opening....
Company:Oasis Medical

Flow Controller

Description:...low Controllers may be used when total punctum occlusion is too much. The tapered shaft is designed to create a vector force, keeping it snugly in the punctal opening where it can be monitored. Designed For: Regulated flow Maximal retention Easy insertion Flesh-like comfort Reversibility ...
Company:EagleVision, Inc.

Tears Naturale™

Description:... Patients who need punctal occlusion want more than just dry eye relief. They also want their punctal plug to be as comfortable and as unobtrusive as possible. Which is why Alcon punctal plugs are growing in popularity with eye care prof...
Company:Alcon Laboratories

More>>

Punctal in Biological Technology

QLT reports initial proof of concept data for punctal plug delivery technology

Small study supports the potential for QLT's drug elution technology to reduce and sustain intraocular pressure VANCOUVER, May 12 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) announced today results from a proof of concept trial conducted by QLT's wholly-owned subs...